by telrheum | May 25, 2024 | IgG4-Related Diseases, Low Complements
Background IgG4-related disease (IgG4-RD) is an autoimmune condition that can affect various organs. Some patients with IgG4-RD have low levels of complement proteins in their blood. This study aimed to compare the characteristics and disease activity of IgG4-RD...
by telrheum | May 21, 2024 | Uncategorized
Researchers at the University of Kentucky studied whether Paxlovid, an antiviral drug, can help prevent hospitalizations and deaths due to COVID-19 in people with rheumatological diseases like rheumatoid arthritis. These diseases often require treatments that suppress...
by telrheum | May 19, 2024 | Autoimmune Diseases, Biologic Therapy, Pneumocystis Jirovecii
This systematic review and meta-analysis led by Athanasios Vassilopoulos and colleagues focuses on the effectiveness of prophylactic Trimethoprim-Sulfamethoxazole (TMP/SMX) in preventing Pneumocystis Jirovecii Pneumonia (PJP) among patients with Autoimmune...
by telrheum | May 19, 2024 | Il-6 inhibitors, Hepatitis B, Infections, JAK Inhibitor
This study, presented at ACR Convergence 2023 by Akhil Sood, Janice Lin, and Neha Shah from Stanford University, examines the risk of Hepatitis B virus (HBV) reactivation in patients with rheumatoid arthritis (RA) who are being treated with either JAK inhibitors or...
by telrheum | May 19, 2024 | Biologic Therapy, Infections, Lupus, Rheumatoid Arthritis, Rituximab, Vasculitis
The article “Risk of Severe Infections Associated with Immunoglobulin Deficiency Under Rituximab Therapy in Immune Mediated Inflammatory Diseases” by Claire Rempenault and colleagues evaluates the connection between severe infections and immunoglobulin deficiency in...